MIKEY501 Thursday, 12/21/17 03:43:58 PM Re: NorFoster post# 87 Post # of 101 NSAV news out on contract with LLY $$$$$$$$$$$$$$ NSAV 8-K officially Eli LillY contract VSRI 12/21/2017 Shanghai based Vital Strategic Research Institute (VSRI), has signed an agreement with Eli Lilly and Company. Under the terms of the agreement, VSRI will provide Eli Lilly with an assessment of Cardio Vascular Disease (CVD) among newly diagnosed diabetes patients at increased risk of CVD in China *******Copie of Contract************* http://nsavholdinginc.com/files/VSRI-Eli-Lilly.pdf Ceo James Tilton wants to be clear with everything Officieel op Sec EDGAR Search Results https://www.sec.gov/cgi-bin/browse-edgar?company=Net+Savings+Link%2C+Inc.&owner=exclude&action=getcompany OTC Reporting https://www.otcmarkets.com/stock/NSAV/news ELI LILLY AND COMPANY AND SUBSIDIARIES 2016 Financial Highlights>>>> Revenu 2016 $ 21Billion !!! Netto income 2.7Billion https://en.wikipedia.org/wiki/Eli_Lilly_and_Company Eli Lilly builds $23B-plus Sales Forecast for 2017 on diabetes, cancer launches https://www.fiercepharma.com/pharma/facing-cialis-patent-expiration-and-pricing-strife-diabetes-eli-lilly-eyes-new-launches-for **China spends $50 billion treating diabetes and related diseases every year, https://blogs.wsj.com/chinarealtime/2016/11/14/chinas-diabetes-problem-from-1-to-10-in-36-years/ **China, about 230 million people have cardiovascular disease.1 http://www.wpro.who.int/china/mediacentre/factsheets/cvd/en/ ELI LILLY AND CO Share price $ 87.00 Not a bad company to work with!!! https://www.marketwatch.com/investing/stock/lly Never buy or sell based on anything I post - MY POSTS ARE ALWAYS JUST MY OPINION, regardless whether I include that in my post or not. I am not a financial advisor and anything I post should be considered only my opinion at that time.